The Expanding Use of Continuous Glucose Monitoring in Type 2 Diabetes
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Perceived social support contributes to self-management activities and outcomes.
“Similar to other peer support studies, we observed improvements in perceived social support, which contributes to self-management activities and outcomes.57,58,59”
From Mobile Health Intervention in Patients With Type 2 Diabetes: A Randomized Clinical Trial (2023) · cites this paper as [57]
Health coaches demonstrated potential in increasing technology use in diabetes management (eg, telehealth or continuous glucose monitoring).
“Health coaches demonstrated potential in increasing technology use in diabetes management (eg, telehealth or, more recently, continuous glucose monitoring60,61).”
From Mobile Health Intervention in Patients With Type 2 Diabetes: A Randomized Clinical Trial (2023) · cites this paper as [61]
Cites
Social determinants of health and diabetes: A scientific review
Hill-Briggs, F., Adler, N. E., Berkowitz, S. A., Chin, M. H., Gary-Webb, T. L., Navas-Acien, A., Thornton, P. L., & Haire-Joshu, D. (2021) · Diabetes Care · doi:10.2337/dci20-0053 · Cited by 1,732 · see citing works
6. Glycemic Targets: <i>Standards of Medical Care in Diabetes—2022</i>
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s006 · Cited by 1,403 · see citing works
Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2855 · Cited by 635 · see citing works
Haak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-016-0223-6 · Cited by 623 · see citing works
Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., Pop-Busui, R., Philis-Tsimikas, A., Bao, S., Umpierrez, G., et al. (2021) · JAMA · doi:10.1001/jama.2021.7444 · Cited by 543 · cited 3× · see citing works
“8,34 In addition, Medicare requirements for CGM approval represent an administrative barrier.”
7. Diabetes Technology: <i>Standards of Medical Care in Diabetes—2022</i>
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s007 · Cited by 358 · see citing works
Vigersky, R. A., Fonda, S. J., Chellappa, M., Walker, M. S., & Ehrhardt, N. M. (2011) · Diabetes Care · doi:10.2337/dc11-1438 · Cited by 304 · see citing works
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288 · see citing works
Peters, A. L., Ahmann, A. J., Battelino, T., Evert, A., Hirsch, I. B., Murad, M. H., Winter, W. E., & Wolpert, H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2534 · Cited by 250 · see citing works
Yoo, H. J., An, H. G., Park, S. Y., Ryu, O. H., Kim, H. Y., Seo, J. A., Hong, E. G., Shin, D. H., Kim, Y. H., Kim, S. G., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.06.015 · Cited by 244 · see citing works
The Clinical Endocrinology Workforce: Current Status and Future Projections of Supply and Demand
Vigersky, R. A., Fish, L., Hogan, P., Stewart, A., Kutler, S., Ladenson, P. W., McDermott, M., & Hupart, K. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2257 · Cited by 238 · see citing works
Ruedy, K. J., Parkin, C. G., Riddlesworth, T. D., & Graham, C. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817704445 · Cited by 225 · see citing works
Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus
Lin, R., Brown, F., James, S., Jones, J., & Ekinci, E. (2021) · Diabetic Medicine · doi:10.1111/dme.14528 · Cited by 197 · see citing works
Karter, A. J., Parker, M. M., Moffet, H. H., Gilliam, L. K., & Dlott, R. (2021) · JAMA · doi:10.1001/jama.2021.6530 · Cited by 191 · see citing works
Haak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0255-6 · Cited by 188 · see citing works
Racial–Ethnic Disparities in Diabetes Technology use Among Young Adults with Type 1 Diabetes
Agarwal, S., Schechter, C., Gonzalez, J., & Long, J. A. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0338 · Cited by 182 · see citing works
Addressing Literacy and Numeracy to Improve Diabetes Care
Cavanaugh, K. L., Wallston, K. A., Gebretsadik, T. S., Shintani, A., Huizinga, M. M., Davis, D., Gregory, R., Malone, R., Pignone, M. P., DeWalt, D. A., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0563 · Cited by 178 · see citing works
Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology
Galindo, R. J., & Aleppo, G. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108502 · Cited by 138 · see citing works
Using Continuous Glucose Monitoring in Clinical Practice
Miller, E. M. (2020) · Clinical Diabetes · doi:10.2337/cd20-0043 · Cited by 125 · see citing works
Wan, W., Skandari, M. R., Minc, A., Nathan, A. G., Winn, A. N., Zarei, P., O’Grady, M. J., & Huang, E. S. (2018) · Diabetes Care · doi:10.2337/dc17-1821 · Cited by 118 · see citing works
The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes
Huang, E. S., O’Grady, M. J., Basu, A., Winn, A. N., John, P. M., Lee, J. M., Meltzer, D. O., Kollman, C., Laffel, L. M., Tamborlane, W. V., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2042 · Cited by 117 · see citing works
Wright, E. E., Kerr, M. S. D., Reyes, I. J., Nabutovsky, Y., & Miller, E. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0069 · Cited by 115 · see citing works
Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring
Jackson, M. A., Ahmann, A., & Shah, V. N. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0007 · Cited by 106 · see citing works
Ida, S., Kaneko, R., & Murata, K. (2019) · Journal of Diabetes Research · doi:10.1155/2019/4684815 · Cited by 86 · see citing works
The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes
Fonda, S. J., Graham, C., Munakata, J., Powers, J. M., Price, D., & Vigersky, R. A. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816628547 · Cited by 81 · see citing works
A virtual type 2 diabetes clinic using continuous glucose monitoring and endocrinology visits
Dixon, R. F., Zisser, H., Layne, J. E., Barleen, N. A., Miller, D. P., Moloney, D. P., Majithia, A. R., Gabbay, R. A., & Riff, J. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819888662 · Cited by 80 · see citing works
Ajjan, R. A., Jackson, N., & Thomson, S. A. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119827456 · Cited by 79 · cited 1× · see citing works
“16 Other RCTs and real-world chart review studies of isCGM have also demonstrated improvement in HbA1c, less time in hypoglycemia and hyperglycemia, and greater time in target range, where higher scanning frequency was associated with more favorable metrics.”
Current Eligibility Requirements for CGM Coverage Are Harmful, Costly, and Unjustified
Anderson, J. E., Gavin, J. R., & Kruger, D. F. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0303 · Cited by 77 · see citing works
A review of flash glucose monitoring in type 2 diabetes
Krakauer, M., Botero, J. F., Lavalle-Gonzalez, F. J., PROIETTI, A. E., & Barbieri, D. E. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00654-3 · Cited by 71 · see citing works
Grace, T., & Salyer, J. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0212 · Cited by 64 · see citing works
Health Care Disparities in Use of Continuous Glucose Monitoring
Isaacs, D. M., Bellini, N. J., Biba, U., Cai, A., & Close, K. L. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0268 · Cited by 62 · see citing works
Espinoza, J., Xu, N. Y., Nguyen, K. T., & Klonoff, D. C. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211058148 · Cited by 46 · see citing works
Diabetes Numeracy and Blood Glucose Control: Association With Type of Diabetes and Source of Care
Zaugg, S. D., Dogbey, G. Y., Collins, K., Reynolds, S., Batista, C., Brannan, G. D., & Shubrook, J. H. (2014) · Clinical Diabetes · doi:10.2337/diaclin.32.4.152 · Cited by 44 · see citing works
Grunberger, G., Handelsman, Y., Bloomgarden, Z., Fonseca, V., Garber, A., Haas, R., Roberts, V., & Umpierrez, G. (2018) · Endocrine Practice · doi:10.4158/ps-2017-0155 · Cited by 44 · see citing works
Oser, T. K., Litchman, M. L., Allen, N. A., Kwan, B. M., Fisher, L., Jortberg, B. T., Polonsky, W. H., & Oser, S. M. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01408-1 · Cited by 43 · see citing works
Polonsky, W. H., & Fortmann, A. L. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0466 · Cited by 41 · see citing works
Sherrill, C. H., Houpt, C. T., Dixon, E. M., & Richter, S. J. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.5.600 · Cited by 39 · see citing works
Effect of Professional CGM (pCGM) on Glucose Management in Type 2 Diabetes Patients in Primary Care
Simonson, G. D., Bergenstal, R. M., Johnson, M. L., Davidson, J. L., & Martens, T. W. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821998724 · Cited by 37 · see citing works
García‐Lorenzo, B., Rivero‐Santana, A., Vallejo‐Torres, L., Castilla‐Rodríguez, I., García‐Pérez, S., García‐Pérez, L., & Perestelo‐Pérez, L. (2018) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12987 · Cited by 36 · see citing works
Galindo, R. J., Parkin, C. G., Aleppo, G., Carlson, A. L., Kruger, D. F., Levy, C. J., Umpierrez, G. E., & McGill, J. B. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0107 · Cited by 36 · see citing works
Barua, S., Sabharwal, A., GLANTZ, N. M., Conneely, C., LAREZ, A. J., Bevier, W. C., & Kerr, D. E. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100853 · Cited by 34 · see citing works
Gal, R. L., Cohen, N., Kruger, D. F., Beck, R. W., Bergenstal, R. M., Calhoun, P. M., Cushman, T., Haban, A., Hood, K. K., Johnson, M. L., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa076 · Cited by 33 · see citing works
Walker, A. F., Cuttriss, N., Haller, M. J., Hood, K. K., Gurka, M. J., Filipp, S. L., ANEZ-ZABALA, C., Yabut, K., Roque, X., Wong, J. J., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002262 · Cited by 33 · see citing works
Yingling, L., Allen, N. A., Litchman, M. L., Colicchio, V. D., & Gibson, B. (2019) · JMIR Diabetes · doi:10.2196/12936 · Cited by 29 · see citing works
Tsuji, S., Ishikawa, T., Morii, Y., Zhang, H., Suzuki, T., Tanikawa, T., Nakaya, J., & Ogasawara, K. (2020) · Journal of Medical Internet Research · doi:10.2196/16053 · Cited by 28 · see citing works
The Role of Reimbursement in the Adoption of Continuous Glucose Monitors
Bartelme, A., & Bridger, P. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300449 · Cited by 24 · see citing works
Peters, A. L., Ahmann, A., Hirsch, I. B., & Raymond, J. K. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00262 · Cited by 19 · see citing works
Broadening Access to Continuous Glucose Monitoring for Patients With Type 2 Diabetes
Peek, M. E., & Thomas, C. C. (2021) · JAMA · doi:10.1001/jama.2021.6208 · Cited by 19 · see citing works
Start-ups Tout Continuous Glucose Monitoring for People Without Diabetes
Jaklevic, M. C. (2021) · JAMA · doi:10.1001/jama.2021.3789 · Cited by 16 · see citing works
Glycemic control and sponsor rank of military dependents with type 1 diabetes mellitus
Paz, R., Rouhanian, M., & Vogt, K. S. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12306 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Oser, T. K., Hall, T. L., Dickinson, L. M., Callen, E. F., Carroll, J. K., Nease, D. E., Michaels, L. C., & Oser, S. M. (2022) · The Annals of Family Medicine · doi:10.1370/afm.2876 · Cited by 79 · see citing works
Mobile Health Intervention in Patients With Type 2 Diabetes: A Randomized Clinical Trial
Gerber, B. S., Biggers, A., Tilton, J. J., Smith Marsh, D. E., Lane, R., Mihailescu, D., Lee, J., & Sharp, L. K. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.33629 · Cited by 61 · see citing works
Self-citationVrany, E. A., Hill‐Briggs, F., Ephraim, P. L., Myers, A. K., Garnica, P., & Fitzpatrick, S. L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1083145 · Cited by 35 · see citing works
The Evolution of Diabetes Technology – Options Toward Personalized Care
Zahid, M., Dowlatshahi, S., Kansara, A., & Sadhu, A. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.04.007 · Cited by 22 · see citing works
Barua, S., GLANTZ, N. M., LAREZ, A. J., Bevier, W. C., Sabharwal, A., & Kerr, D. E. (2024) · Scientific Reports · doi:10.1038/s41598-024-52461-1 · Cited by 11 · see citing works
G6 continuous glucose monitoring system feature use and its associations with glycaemia in Europe
Acciaroli, G., Parkin, C. G., Thomas, R., Layne, J. E., Norman, G. J., & Leone, K. (2023) · Diabetic Medicine · doi:10.1111/dme.15093 · Cited by 11 · see citing works
Ebekozien, O. A. (2023) · Diabetes Spectrum · doi:10.2337/dsi23-0002 · Cited by 9 · see citing works
- Authors
- Dabbagh, Z., McKee, M. D., Pirraglia, P. A., Clements, K. M., Liu, F., Amante, D. J., Shukla, P., & Gerber, B. S.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Gerber, Ben S.
- ORCID
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2022-06-29
- Volume
- 24
- Issue
- 7
- Pages
- 510-515
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W4214845993
- Cited by
- 7
- References
- 50
- Citations by year
- 2024: 1 · 2023: 5 · 2022: 1
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Technology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- continuous glucose monitoring, type 2 diabetes, diabetes management, glycemic control
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Hypoglycemia, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review